Vanda Pharmaceuticals
VNDA
VNDA
115 hedge funds and large institutions have $434M invested in Vanda Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
5% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 21
8% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 39
Holders
115
Holding in Top 10
5
Calls
$7.42M
Puts
$2.23M
Top Buyers
| 1 | +$20.5M | |
| 2 | +$5.39M | |
| 3 | +$4.42M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$3.96M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$2.19M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$14.1M | |
| 3 | -$12M | |
| 4 |
AC
Armistice Capital
New York
|
-$8.95M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$4.56M |